U.S. pharmaceutical stocks continued to rise, according to MSX.COM data, with AstraZeneca leading the move after posting quarterly results. The company climbed more than 6% after its earnings release, as third-quarter profit came in above expectations. Other major drugmakers also advanced during the session. Eli Lilly and Gilead Sciences each gained more than 4%, while Amgen rose nearly 3% and Johnson & Johnson added close to 2%. The report said all of these stocks hit record highs intraday. The move kept the broader healthcare and pharmaceutical segment on an upward track in U.S. equities.
U.S. pharmaceutical stocks continued higher, according to data from MSX.COM.
AstraZeneca rose more than 6% after releasing earnings, with its third-quarter profit beating expectations. Eli Lilly and Gilead Sciences each gained more than 4%, Amgen rose nearly 3%, and Johnson & Johnson added close to 2%. All of the stocks mentioned hit record highs during intraday trading.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
